Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1023]

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG

Dr Roger Li - Moffitt Cancer Center, Tampa, USA

CG0070 plus pembro shows promising efficacy in NMIBC unresponsive to BCG ( Dr Roger Li - Moffitt Cancer Center, Tampa, USA )

ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance

Prof Heather Payne and Dr Jochen Walz

ASCO GU 2023: Prostate QoL data and apalutamide plus active surveillance ( Prof Heather Payne and Dr Jochen Walz )

Time toxicity: opportunity costs of low value cancer treatment

Dr Christopher Booth - Queen's University, Kingston, Canada

Time toxicity: opportunity costs of low value cancer treatment ( Dr Christopher Booth - Queen's University, Kingston, Canada )

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy...

Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ( Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia )

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free...

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany

Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival via PSMA-radioguided surgery ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable...

Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany

Diagnostic performance of 18F-rhPSMA-7.3 PET in newly diagnosed unfavourable intermediate to very high-risk prostate cancer ( Prof Tobias Maurer - Martini-Klinik Prostate Cancer Center, Hamburg, Germany )

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti...

Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy

Pembro monotherapy for participants with BCG–unresponsive HR NMIBC shows anti-tumour activity ( Prof Andrea Necchi - The Vita-Salute San Raffaele University, Milan, Italy )

Digital rectal examination is not useful as a solitary screening tool for...

Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )

Single intensive screening intervention using PSA and Stockholm3 in combination...

Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany

Single intensive screening intervention using PSA and Stockholm3 in combination might reduce prostate cancer mortality ( Prof Peter Albers - Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany )

Intravesical IO using durvalumab shows promising results for patients with high...

Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece

Intravesical IO using durvalumab shows promising results for patients with high risk NMIBC after BCG failure ( Dr Charalampos Fragkoulis - General Hospital of Athens, Athens, Greece )

Surgical technique remains the most important factor associated with recovery...

Dr Rafael Sanchez-Salas - McGill University Health Center, Montreal, Canada

Surgical technique remains the most important factor associated with recovery of urinary continence after radical prostatectomy ( Dr Rafael Sanchez-Salas - McGill University Health Center, Montreal, Canada )

EAU 2023: Treatment landscape for early-stage bladder cancer

Dr Bernadett Szabados, Prof Rob Jones, Dr Félix Guerrero-Ramos and Dr Cosimo De...

EAU 2023: Treatment landscape for early-stage bladder cancer ( Dr Bernadett Szabados, Prof Rob Jones, Dr Félix Guerrero-Ramos and Dr Cosimo De Nunzio )

More from ecancer